8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Revenue growth under 50% of 2127.T's 24.34%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.53%
Gross profit growth under 50% of 2127.T's 60.37%. Michael Burry would be concerned about a severe competitive disadvantage.
43.67%
EBIT growth below 50% of 2127.T's 91.67%. Michael Burry would suspect deeper competitive or cost structure issues.
30.10%
Operating income growth under 50% of 2127.T's 87.98%. Michael Burry would be concerned about deeper cost or sales issues.
42.72%
Net income growth at 50-75% of 2127.T's 68.70%. Martin Whitman would question fundamental disadvantages in expenses or demand.
42.72%
EPS growth at 50-75% of 2127.T's 68.68%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
42.72%
Diluted EPS growth at 50-75% of 2127.T's 64.77%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 2127.T is at 2.23%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.78%
10Y revenue/share CAGR under 50% of 2127.T's 323.19%. Michael Burry would suspect a lasting competitive disadvantage.
-7.65%
Negative 5Y CAGR while 2127.T stands at 277.71%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
35.01%
3Y revenue/share CAGR under 50% of 2127.T's 114.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.39%
Below 50% of 2127.T's 393.98%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
2.81%
Below 50% of 2127.T's 473.45%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
47.84%
Below 50% of 2127.T's 147.90%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
28.23%
Below 50% of 2127.T's 194.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.77%
3Y equity/share CAGR at 50-75% of 2127.T's 99.58%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.16%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.48%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.44%
Positive asset growth while 2127.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.18%
BV/share growth above 1.5x 2127.T's 1.89%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-25.72%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
101.71%
SG&A growth well above 2127.T's 10.15%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.